Procarta CEO attends the Berlin CMR Conference 2019

Procarta Biosystems Ltd. attended the Berlin Novel Antimicrobials and AMR Diagnostics Conference 2019. 

Dr Andrew Lightfoot, CEO Procarta, commented “This fantastic conference highlighted the successful ‘push’ incentives to create and build antibiotic companies, such as REPAIR and CARB-X and also highlighted the need for ‘pull’ incentives for those further along the track to market.  The cutting edge science, policy reviews, reality checks as well as continued enthusiasm for tackling AMR was crammed into this conference – a must for next year”



More news stories